Adagrasib Market Analysis by Indication (Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Other Solid Tumors), By Treatment Type (Monotherapy, Combination Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region: Global Forecast, 2024 - 2034

  • 2024-05-03
  • 191
  • Healthcare & Life Sciences

Market Overview

The Adagrasib market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.


SOURCE: We Market Research

Adagrasib is a medication used in targeted therapy that blocks KRAS G12C, a particular kind of mutant protein. This mutation is frequently detected in some cancer types, including colorectal and non-small cell lung cancer (NSCLC). Adagrasib functions by preventing the mutant KRAS protein from acting, which is essential in fostering the development of cancer. Adagrasib works to slow down or stop the proliferation of cancer cells that carry the KRAS G12C mutation by blocking this protein. It is being investigated in clinical studies for its efficacy and safety in treating various kinds of tumors, and it represents a potential strategy in targeted cancer therapy.

Mirati Therapeutics produced the oral small-molecule KRAS inhibitor Adagrasib (MRTX849). KRAS mutations make up about 85% of all RAS family mutations and are extremely prevalent in cancer. However, because of their strong affinity for GTP and GDP and because they lack a well-defined binding site, the creation of KRAS inhibitors has proven difficult. Adagrasib suppresses KRAS-dependent signaling by targeting the cysteine 12 residue of KRASG12C, one of the most prevalent KRAS mutations. Adagrasib demonstrated anti-tumor effects in a phase I/IB clinical research including patients with advanced solid tumors with mutations in KRASG12C (NCT03785249). Phase II of the same trial demonstrated that adagrasib was effective without additional safety signals in patients with non-small-cell lung cancer (NSCLC) with a mutation in the KRASG12C gene. 

Market Scope

Report Attributes


Market Size in 2024

USD XX Million

Market Forecast in 2034

USD XX Million

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Indication, By Treatment Type, By Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria


Adagrasib Industry: Dynamics & Restrains

 Market opportunity:


We Market Research: Adagrasib Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Adagrasib Segmentation

Market- By Indication Analysis

By Indication, the Adagrasib Market is Categories into Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Other Solid Tumors. The Non-Small Cell Lung Cancer (NSCLC) segment accounts for the largest share of around 68% in 2024.

Adagrasib is used to treat non-small cell lung cancer (NSCLC) because of its potency against certain genetic alterations, such as KRAS G12C, which is frequently present in NSCLC patients. Adagrasib is a viable treatment option for individuals with NSCLC who have this genetic alteration because of its focused suppression of this mutation, which lowers tumor growth.

The following segments are part of an in-depth analysis of the global Adagrasib market:

Market Segments


By  Treatment Type

·         Monotherapy

·         Combination Therapy

By  Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies


Adagrasib Industry: Regional Analysis

North America Market Forecast

North America dominate the Adagrasib Market with the highest revenue generating market with share of more than 47%. Adagrasib is widely utilized in the treatment of NSCLC patients, owing to the high frequency of KRAS G12C mutations, particularly in the United States and Canada. Adagrasib's use in this arena has been accelerated by the FDA's approval of the medicine for NSCLC patients with KRAS G12C mutations.

Europe Market Statistics

Europe is the second largest region in Adagrasib market, due the factors driving market expansion include increased awareness of precision medicine, favorable government initiatives supporting cancer research, and the presence of significant pharmaceutical companies creating novel medicines such as Adagrasib. Furthermore, connections between academic institutions and pharmaceutical businesses help to strengthen research activities in the region.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Adagrasib market during the forecast period. The Adagrasib market in Asia Pacific region is fueled by factors such as a huge population base, rising cancer incidence, and improved healthcare infrastructure. Furthermore, rising healthcare expenditure, increased investments in the biotechnology and pharmaceutical sectors, and expanding knowledge about customized medicine all contribute to market growth in countries such as China, India, and Japan.

Key Market Players        

The Adagrasib Market is dominated by a few large companies, such as

·         Mirati Therapeutics

·         Amgen

·         Other

1.      Global Adagrasib Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Adagrasib Market Scope and Market Estimation

1.2.1. Global Adagrasib Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Adagrasib Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Adagrasib Market

1.3.2. Technology of Global Adagrasib Market

1.3.3. Distribution Channel of Global Adagrasib Market

1.3.4. Region of Global Adagrasib Market

2.      Executive Summary

2.1.    Global Adagrasib Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Adagrasib Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Adagrasib Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Adagrasib Market Estimates & Forecast Trend Analysis, by INDICATION

4.1.    Global Adagrasib Market Revenue (US$ Mn) Estimates and Forecasts, by INDICATION, 2019 to 2034

4.1.1. Non-Small Cell Lung Cancer (NSCLC)

4.1.2. Colorectal Cancer

4.1.3. Other Solid Tumors

5.      Global Adagrasib Market Estimates & Forecast Trend Analysis, by Treatment Type

5.1.    Global Adagrasib Market Revenue (US$ Mn) Estimates and Forecasts, by Treatment Type, 2019 to 2034

5.1.1. Monotherapy

5.1.2. Combination Therapy

6.      Global Adagrasib Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Adagrasib Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

7.      Global Adagrasib Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Adagrasib Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Adagrasib Market: Estimates & Forecast Trend Analysis

8.1.    North America Adagrasib Market Assessments & Key Findings

8.1.1. North America Adagrasib Market Introduction

8.1.2. North America Adagrasib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By INDICATION   By Treatment Type   By Distribution Channel   By Country     The U.S.     Canada     Mexico

9.      Europe Adagrasib Market: Estimates & Forecast Trend Analysis

9.1.    Europe Adagrasib Market Assessments & Key Findings

9.1.1. Europe Adagrasib Market Introduction

9.1.2. Europe Adagrasib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By INDICATION   By Treatment Type   By Distribution Channel        By Country     Germany     U.K.     France     Italy     Spain     Russia     Rest of Europe

10.  Asia Pacific Adagrasib Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Adagrasib Market Introduction

10.1.2.   Asia Pacific Adagrasib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Treatment Type    By Distribution Channel    By Country China Japan India Australia South Korea ASEAN Rest of Asia Pacific

11.  Middle East & Africa Adagrasib Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Adagrasib Market Introduction

11.1.2.   Middle East & Africa Adagrasib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Treatment Type    By Distribution Channel    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

12.  South America Adagrasib Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Adagrasib Market Introduction

12.1.2.   South America Adagrasib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Treatment Type    By Distribution Channel    By Country Brazil Argentina Colombia Rest of South America

13.  Competition Landscape

13.1.  Global Adagrasib Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Adagrasib Market Competition White Space Analysis, By Distribution Channel

13.3.  Global Adagrasib Market Competition Heat Map Analysis, By Distribution Channel

13.4.  Global Adagrasib Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Mirati Therapeutics

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Amgen

14.3.      Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Adagrasib Market in 2024?

Adagrasib Market was valued at USD XX Million in 2024.

What is the growth rate for the Adagrasib Market?

Adagrasib Market size will increase at approximate CAGR of XX% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Adagrasib Market Are Mirati Therapeutics, Amgen and Other.

Which region dominates the Adagrasib Market?

North America dominates the market with an active share of 47%.


Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI